Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712
- Citation:
- J Clin Oncol vol 29 (10) 1349-1355
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 390
- Children:
- None
- Pharmas:
- Grants:
- P50 CA140158, U10 CA031946, CA31946, P50 CA140158-02
- Corr. Author:
- Authors:
- Jennifer A. Woyach Amy S. Ruppert Nyla A. Heerema Bercedis L. Peterson John G. Gribben Vicki A. Morrison Kanti R. Rai Richard A. Larson John C. Byrd
- Networks:
- Study
- CALGB-9712
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Hema6, Original Reports, Hematologic Malignancies